Yuhan Corporation Holds 100th General Meeting of Shareholders... 400 Won Dividend per Common Share

Yuhan Corporation announced on the 23rd that it held the 100th Annual General Meeting of Shareholders at its headquarters auditorium in Daebang-dong, Dongjak-gu, Seoul, with shareholders in attendance.

At this general meeting, Yuhan reported last year's operating performance with separate basis sales of 1,726,364,620,000 KRW, operating profit of 41,119,510,000 KRW, and net profit of 130,274,120,000 KRW.

In his greeting, Yuhan President Jo Wook-je said, “Despite the challenging environment of the COVID-19 pandemic, the Russia-Ukraine war, US-China trade conflicts, and global inflation, it was a year of various achievements thanks to the passionate support of our shareholders and the dedicated efforts of our employees. We will strive to achieve Yuhan’s vision of ‘Great Yuhan, Global Yuhan’ led by the global innovative new drug ‘Reclaza’ for the upcoming creation of Yuhan’s 100-year history.”

During the subsequent agenda review, the reappointment of two outside directors, Professor Ji Sung-gil of Korea University’s Department of Life Sciences and Dean Park Dong-jin of Yonsei University Law School, was approved. Additionally, a cash dividend totaling 27.2 billion KRW was decided, with 400 KRW per common share and 410 KRW per preferred share.